Bernheim 2020
Chest CT Findings in Coronavirus Disease-19 (COVID-19): relationship to Duration of Infection
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  3. Mechanism
  1. Study Design
  2. Cross-sectional
  1. Intervention Assignment
  2. Not Applicable
References (1)
Bordi 2020
Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020
  1. Study Type
  1. Study Aim
  1. Study Design
  1. Intervention Assignment
References (1)
Cai 2020
Analysis of bronchoscope-guided tracheal intubation in 12 cases with COVID-19 under the personal protective equipment with positive pressure protective hood
  1. Study Type
  2. Observational
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
  1. Population (7)
  2. Male and Female
  3. COVID-19
  4. Adult
  5. Aged (65+)
  1. Intervention (0)
  1. Comparison (0)
  1. Outcome (0)
References (1)
Cai 2020a
First case of 2019 novel coronavirus infection in children in Shanghai
  1. Study Type
  2. Observational
  1. Study Aim
  2. Mechanism
  1. Study Design
  2. Case Report
  1. Intervention Assignment
  2. Not Applicable
References (1)
Cai 2020b
A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features
  1. Study Type
  2. Observational
  1. Study Aim
  2. Epidemiology
  3. Mechanism
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
References (1)
NCT04252664
A Phase 3 Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Efficacy and Safety of Remdesivir in Hospitalized Adult Patients With Mild and Moderate 2019-nCoV Respiratory Disease
  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Parallel/Crossover
  1. Intervention Assignment
  2. Randomised
  1. Population (8)
  2. Male and Female
  3. COVID-19
  4. SARS-CoV-2 Virus
  5. Adult
  6. Aged (65+)
  1. Intervention (1)
  2. Remdesivir
  1. Comparison (1)
  2. Placebo
  1. Outcome (8)
  2. Serious Adverse Event
  3. Oxygen Supplementation
  4. Viral load
  5. All Cause Mortality
  6. Dyspnea
  7. Time to clinical recovery
  8. Mechanical ventilation
  9. SARS-CoV-2 RT-PCR
References (3)
NCT04257656
A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Remdesivir in Hospitalized Adult Patients With Severe 2019-nCoVRespiratory Disease
  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Parallel/Crossover
  1. Intervention Assignment
  2. Randomised
  1. Population (9)
  2. Male and Female
  3. Hospitalization
  4. COVID-19
  5. Reverse transcription polymerase chain reaction
  6. Adult
  7. Aged (65+)
  1. Intervention (1)
  2. Remdesivir
  1. Comparison (1)
  2. Placebo
  1. Outcome (11)
  2. Death
  3. Hospitalization
  4. Serious Adverse Event
  5. Time to clinical improvement
  6. All Cause Mortality
  7. Oxygen Supplementation
  8. Viral load
  9. Extracorporeal Membrane Oxygenation
  10. SARS-CoV-2 RT-PCR
  11. Duration Of Hospital Stay
References (3)
NCT04313127
A Single-center,Open-label，Dose-escalating Phase I Clinical Trial to Evaluate Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Healthy Adults Aged 18-60 Years Old
  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Single Arm/Controlled Before After
  1. Intervention Assignment
  2. Not Applicable
References (1)
ChiCTR2000030782
The value of CD4 / CD8 cells, CRP / ALB and APCHEII in novel coronavirus pneumonia (COVID-19)
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  3. Mechanism
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
References (1)
ChiCTR2000030476
Study for meditation assists for the rehabilitation of patients with novel coronaviruse pneumonia (COVID-19)
  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Parallel/Crossover
  1. Intervention Assignment
  2. Unclear
References (1)
NCT04302519
Clinical Study of Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells
  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Single Arm/Controlled Before After
  1. Intervention Assignment
  2. Not Applicable
References (1)
NCT04316728
Clinical Performance of the VivaDiag ™ COVID-19 lgM / IgG Rapid Test in a Cohort of Negative Patients for Coronavirus Infection for the Early Detection of Positive Antibodies for COVID-19
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
References (1)
ChiCTR2000030543
Detection of coronavirus in simultaneously collecting tears and throat swab samples collected from the patients with novel coronavirus pneumonia (COVID-19)
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  3. Mechanism
  1. Study Design
  2. Unclear
  1. Intervention Assignment
  2. Not Applicable
References (1)
ChiCTR2000030196
A multicenter, single arm, open label trial for the efficacy and safety of CMAB806 in the treatment of cytokine release syndrome of novel coronavirus pneumonia (COVID-19)
  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Single Arm/Controlled Before After
  1. Intervention Assignment
  2. Not Applicable
References (1)
ChiCTR2000029869
A multicenter, randomized, controlled trial for integrated Chinese and western medicine in the treatment of ordinary novel coronavirus pneumonia (COVID-19) based on the ' Internal and External Relieving -Truncated Torsion' strategy
  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Parallel/Crossover
  1. Intervention Assignment
  2. Randomised
  1. Population (7)
  2. Male and Female
  3. COVID-19
  4. Adult
  5. Aged (65+)
  1. Intervention (2)
  2. Drug Therapy
  3. Truncated Torsion Strategy
  1. Comparison (1)
  2. Drug Therapy
  1. Outcome (5)
  2. Clinical Improvement
  3. Critical COVID-19
  4. Death
  5. Coagulation
  6. Oxygenation Index
References (1)
0 Selected
ExportClear